Equus Total Return, Inc.: notified of NYSE noncompliance with $1.00 price rule

What happened

• The company was notified by the New York Stock Exchange on Oct 6, 2026 that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the company’s Common Stock was less than $1.00 over a consecutive 30 trading-day period.
• The company plans to notify the NYSE by Oct 20, 2026 that it intends to cure the average closing stock price deficiency and issued a press release on Oct 13, 2026 reporting the notice.

Key details

• The NYSE notice does not result in immediate delisting; the company has a 6-month cure period following receipt of the notice.
• To regain compliance, on the last trading day of any calendar month during the cure period the company must have (i) a closing share price of at least $1.00 and (ii) an average closing share price of at least $1.00 over the 30 trading-day period ending on that day.
• The company intends to consider alternatives to cure the non-compliance, including, but not limited to, a reverse stock split.
• The company furnished a press release dated Oct 13, 2026 as Exhibit 99.1.

Why it may matter

• Item 3.01 was reported: notice of delisting or failure to satisfy a continued listing rule or standard, covering noncompliance with the NYSE $1.00 average closing price requirement and the company’s plan to seek cure. Item 7.01 was reported: Regulation FD disclosure via a press release on Oct 13, 2026.
• This filing does not show why the insider traded or why the company acted.